Tirofiban (INN, trade name Aggrastat) is an antiplatelet drug. It belongs to a class
of antiplatelet named glycoprotein IIb/IIIa inhibitors. Tirofiban is the first drug ...
Jul 6, 2016 ... AGGRASTAT contains tirofiban hydrochloride, a non-peptide antagonist of the
platelet GP IIb/IIIa receptor, which inhibits platelet aggregation.
Welcome to AGGRASTAT.com. The information contained here is intended for.
HEALTHCARE PROFESSIONALS ONLY. For Non-US Healthcare Professionals
(1)Adis International Limited, Auckland, New Zealand. email@example.com.
Tirofiban is an intravenously administered nonpeptide glycoprotein IIb/IIIa
AGGRASTAT* (tirofiban hydrochloride), a non-peptide antagonist of the platelet
... Tirofiban hydrochloride monohydrate is a white to off-white, non-hygroscopic, ...
AGGRASTAT (Tirofiban) drug information & product resources from MPR
including dosage information, educational materials, & patient assistance.
Consumer information about the medication TIROFIBAN - INJECTION (Aggrastat)
, includes side effects, drug interactions, recommended dosages, and storage ...
Jun 13, 2005 ... Description, Tirofiban prevents the blood from clotting during episodes of chest
pain or a heart attack, or while the patient is undergoing a ...
May 16, 2016 ... Tirofiban helps to prevent platelets in your blood from sticking together and
forming a blood clot. An unwanted blood clot can occur with certain ...